Even patch pumps could be vulnerable to infusion set issues (see Table two). The event of extra steady strategies for subcutaneous insulin infusion could benefit all insulin pump wearers. Integration of constant ketone monitors, that have been assessed in compact medical feasibility trials, may well deliver an added protection feature to assist met